Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1985 Oct;40(10):760–767. doi: 10.1136/thx.40.10.760

Mast cell and histamine content of human bronchoalveolar lavage fluid.

R M Agius, R C Godfrey, S T Holgate
PMCID: PMC460180  PMID: 4060097

Abstract

Bronchoalveolar lavage was performed in 97 patients including control patients with bronchial carcinoma (24) and patients with sarcoidosis (20), cryptogenic fibrosing alveolitis (9), and asthma (4), and others. Cytocentrifuged slides were stained by two methods: May-Grünwald Giemsa and toluidine blue. In the last 32 subjects the bronchoalveolar lavage fluid was separated into supernatant and cell pellet for the subsequent assay of the performed mast cell mediator, histamine. Comparison of the two methods of staining showed a bias towards toluidine blue. Controls had a differential mean (SE) mast cell count of 0.07% (0.01%). Higher counts were noted in cryptogenic fibrosing alveolitis--0.61% (0.15%) (p less than 0.001)--and in sarcoidosis--0.14% (0.02%) (p less than 0.05). There was a strong correlation between absolute mast cell counts and cell lysate histamine concentration (r = 0.78, p less than 0.001). Less strong, significant, correlations between supernatant histamine concentration and absolute mast cell counts (r = 0.48, p less than 0.01) or cell lysate histamine concentration (r = 0.72, p less than 0.01) were also found. Derived mean values of histamine per mast cell ranged from 3.7 to 10.9 picograms. The mean histamine content of lavage fluid supernatant as a percentage of the total lavage fluid histamine was 24.9% (3.3%). The possible clinical significance of these findings is discussed.

Full text

PDF
760

Images in this article

762Image
on p.762

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Church M. K., Pao G. J., Holgate S. T. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol. 1982 Nov;129(5):2116–2121. [PubMed] [Google Scholar]
  2. Cole P., Turton C., Lanyon H., Collins J. Bronchoalveolar lavage for the preparation of free lung cells: technique and complications. Br J Dis Chest. 1980 Jul;74(3):273–278. doi: 10.1016/0007-0971(80)90055-8. [DOI] [PubMed] [Google Scholar]
  3. Enerbäck L. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand. 1966;66(3):303–312. doi: 10.1111/apm.1966.66.3.303. [DOI] [PubMed] [Google Scholar]
  4. Fox B., Bull T. B., Guz A. Mast cells in the human alveolar wall: an electronmicroscopic study. J Clin Pathol. 1981 Dec;34(12):1333–1342. doi: 10.1136/jcp.34.12.1333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goto T., Befus D., Low R., Bienenstock J. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am Rev Respir Dis. 1984 Nov;130(5):797–802. doi: 10.1164/arrd.1984.130.5.797. [DOI] [PubMed] [Google Scholar]
  6. Gustowska L., Ruitenberg E. J., Elgersma A., Kociecka W. Increase of mucosal mast cells in the jejunum of patients infected with Trichinella spiralis. Int Arch Allergy Appl Immunol. 1983;71(4):304–308. doi: 10.1159/000233412. [DOI] [PubMed] [Google Scholar]
  7. Haslam P. L., Cromwell O., Dewar A., Turner-Warwick M. Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol. 1981 Jun;44(3):587–593. [PMC free article] [PubMed] [Google Scholar]
  8. Haslam P. L., Turton C. W., Heard B., Lukoszek A., Collins J. V., Salsbury A. J., Turner-Warwick M. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax. 1980 Jan;35(1):9–18. doi: 10.1136/thx.35.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hogg J. C. Bronchial mucosal permeability and its relationship to airways hyperreactivity. Eur J Respir Dis Suppl. 1982;122:17–22. [PubMed] [Google Scholar]
  10. Kawanami O., Ferrans V. J., Fulmer J. D., Crystal R. G. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest. 1979 Jun;40(6):717–734. [PubMed] [Google Scholar]
  11. Keogh B. A., Hunninghake G. W., Line B. R., Crystal R. G. The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis. 1983 Aug;128(2):256–265. doi: 10.1164/arrd.1983.128.2.256. [DOI] [PubMed] [Google Scholar]
  12. Lamb D., Lumsden A. Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency. Thorax. 1982 May;37(5):334–342. doi: 10.1136/thx.37.5.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nabel G., Galli S. J., Dvorak A. M., Dvorak H. F., Cantor H. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature. 1981 May 28;291(5813):332–334. doi: 10.1038/291332a0. [DOI] [PubMed] [Google Scholar]
  14. Nagao K., Yokoro K., Aaronson S. A. Continuous lines of basophil/mast cells derived from normal mouse bone marrow. Science. 1981 Apr 17;212(4492):333–335. doi: 10.1126/science.7209531. [DOI] [PubMed] [Google Scholar]
  15. Patterson R., McKenna J. M., Suszko I. M., Solliday N. H., Pruzansky J. J., Roberts M., Kehoe T. J. Living histamine-containing cells from the bronchial lumens of humans. Description and comparison of histamine content with cells of rhesus monkeys. J Clin Invest. 1977 Feb;59(2):217–225. doi: 10.1172/JCI108631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rowe D. J., Hayward M., Bagga H., Betts P. Effect of glycaemic control and duration of disease on overnight albumin excretion in diabetic children. Br Med J (Clin Res Ed) 1984 Oct 13;289(6450):957–959. doi: 10.1136/bmj.289.6450.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Saltini C., Hance A. J., Ferrans V. J., Basset F., Bitterman P. B., Crystal R. G. Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis. 1984 Oct;130(4):650–658. doi: 10.1164/arrd.1984.130.4.650. [DOI] [PubMed] [Google Scholar]
  18. Schleimer R. P., MacGlashan D. W., Jr, Peters S. P., Naclerio R., Proud D., Adkinson N. F., Jr, Lichtenstein L. M. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol. 1984 Oct;74(4 Pt 1):473–481. doi: 10.1016/0091-6749(84)90381-6. [DOI] [PubMed] [Google Scholar]
  19. Schulman E. S., Kagey-Sobotka A., MacGlashan D. W., Jr, Adkinson N. F., Jr, Peters S. P., Schleimer R. P., Lichtenstein L. M. Heterogeneity of human mast cells. J Immunol. 1983 Oct;131(4):1936–1941. [PubMed] [Google Scholar]
  20. Strobel S., Busuttil A., Ferguson A. Human intestinal mucosal mast cells: expanded population in untreated coeliac disease. Gut. 1983 Mar;24(3):222–227. doi: 10.1136/gut.24.3.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Studdy P. R., Rudd R. M., Gellert A. R., Uthayakumar S., Sinha G., Geddes D. M. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowing. Br J Dis Chest. 1984 Jan;78(1):46–54. [PubMed] [Google Scholar]
  22. Tomioka M., Ida S., Shindoh Y., Ishihara T., Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis. 1984 Jun;129(6):1000–1005. doi: 10.1164/arrd.1984.129.6.1000. [DOI] [PubMed] [Google Scholar]
  23. Wingren U., Enerbäck L. Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. Histochem J. 1983 Jun;15(6):571–582. doi: 10.1007/BF01954148. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES